TGM5
Protein-glutamine gamma-glutamyltransferase 5
Also known as: TGM5_HUMAN, TGMX, TGX
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O43548
- Gene
- TGM5
- Ensembl
- ENSG00000104055
- Chromosome
- 15
- Canonical length
- 720 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a member of the transglutaminase family. The encoded protein catalyzes formation of protein cross-links between glutamine and lysine residues, often resulting in stabilization of protein assemblies. This reaction is calcium dependent. Mutations in this gene have been associated with acral peeling skin syndrome. [provided by RefSeq, Oct 2009]
Canonical amino-acid sequenceUniProt
720 residues, UniProt reviewed canonical sequence.
>O43548|TGM5
1 MAQGLEVALT DLQSSRNNVR HHTEEITVDH LLVRRGQAFN LTLYFRNRSF QPGLDNIIFV
61 VETGPLPDLA LGTRAVFSLA RHHSPSPWIA WLETNGATST EVSLCAPPTA AVGRYLLKIH
121 IDSFQGSVTA YQLGEFILLF NPWCPEDAVY LDSEPQRQEY VMNDYGFIYQ GSKNWIRPCP
181 WNYGQFEDKI IDICLKLLDK SLHFQTDPAT DCALRGSPVY VSRVVCAMIN SNDDNGVLNG
241 NWSENYTDGA NPAEWTGSVA ILKQWNATGC QPVRYGQCWV FAAVMCTVMR CLGIPTRVIT
301 NFDSGHDTDG NLIIDEYYDN TGRILGNKKK DTIWNFHVWN ECWMARKDLP PAYGGWQVLD
361 ATPQEMSNGV YCCGPASVRA IKEGEVDLNY DTPFVFSMVN ADCMSWLVQG GKEQKLHQDT
421 SSVGNFISTK SIQSDERDDI TENYKYEEGS LQERQVFLKA LQKLKARSFH GSQRGAELQP
481 SRPTSLSQDS PRSLHTPSLR PSDVVQVSLK FKLLDPPNMG QDICFVLLAL NMSSQFKDLK
541 VNLSAQSLLH DGSPLSPFWQ DTAFITLSPK EAKTYPCKIS YSQYSQYLST DKLIRISALG
601 EEKSSPEKIL VNKIITLSYP SITINVLGAA VVNQPLSIQV IFSNPLSEQV EDCVLTVEGS
661 GLFKKQQKVF LGVLKPQHQA SIILETVPFK SGQRQIQANM RSNKFKDIKG YRNVYVDFALLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TGM5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 37 nTPM
Expression across tissuesHPA
Tissue
- skin: 37 nTPM
- esophagus: 11 nTPM
- vagina: 7.5 nTPM
- cervix: 6 nTPM
- salivary gland: 4 nTPM
- tonsil: 2.2 nTPM
Single-cell type
- esophageal apical cells: 134 nCPM
- suprabasal keratinocytes: 32 nCPM
- esophageal suprabasal cells: 21 nCPM
- late spermatids: 12 nCPM
- lacrimal acinar cells: 10 nCPM
- salivary duct cells: 9.3 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- medulla oblongata: 0.7 nTPM
- spinal cord: 0.5 nTPM
- cerebellum: 0.4 nTPM
- midbrain: 0.4 nTPM
- hypothalamus: 0.3 nTPM
- white matter: 0.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TGM5.
Disease | AllUniProt
Conditions TGM5 is implicated in, by any mechanism.
- Peeling skin syndrome 2 (PSS2) MIM:609796
Disease | GeneticClinVar
20 pathogenic / likely-pathogenic of 210 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Acral peeling skin syndrome
- Peeling skin syndrome 1
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.44
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.32
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Transglutaminase, N-terminal
- Transglutaminase-like
- Transglutaminase, C-terminal
- Immunoglobulin-like fold
- Transglutaminase, active site
- Immunoglobulin E-set
- Protein-glutamine gamma-glutamyltransferase, animal
- Transglutaminase, C-terminal domain superfamily
- Transglutaminase-like superfamily
- Papain-like cysteine peptidase superfamily
- Protein-glutamine gamma-glutamyltransferases
- Transglutaminase family
- Transglutaminase family, C-terminal ig like domain
- Transglutaminase-like superfamily
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TGM5 as an antibody target. Whether an autoantibody or antibody against TGM5 could matter depends on whether native TGM5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TGM5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TGM5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...